A study of IPH-4301 for the treatment of cancer
Phase of Trial: Phase I
Latest Information Update: 07 Mar 2017
At a glance
- Drugs IPH 4301 (Primary)
- Indications Cancer
- Focus Adverse reactions
- 07 Mar 2017 According to an Innate Pharma media release, the program IPH4301 has started IND-enabling studies and is expected to enter clinic in 2018.
- 19 Apr 2016 New trial record
- 18 Apr 2016 According to an Innate Pharma media release, this study will start in 2016.